Literature DB >> 18557725

Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h posttransplant in naive recipients.

A D Schenk1, T Nozaki, M Rabant, A Valujskikh, R L Fairchild.   

Abstract

Normal immune responses stimulated by pathogenic and environmental antigens generate memory T cells that react with donor antigens and no currently used immunosuppressive drug completely inhibits memory T-cell function. While donor-reactive memory T cells clearly compromise graft outcomes, mechanisms utilized by memory T cells to promote rejection are largely unknown. In this study, we investigated how early endogenous memory cells infiltrate and express effector function in cardiac allografts. Endogenous CD8 memory T cells in nonsensitized recipients distinguish syngeneic versus allogeneic cardiac allografts within 24 h of reperfusion. CD8-dependent production of IFN-gamma and CXCL9/Mig was observed 24 to 72 h posttransplant in allografts but not isografts. CXCL9 was produced by donor cells in response to IFN-gamma made by recipient CD8 T cells reactive to donor class I major histocompatibility complex (MHC) molecules. Activated CD8 T cells were detected in allografts at least 3 days before donor-specific effector T cells producing IFN-gamma were detected in the recipient spleen. Early inflammation mediated by donor-reactive CD8 memory T cells greatly enhanced primed effector T-cell infiltration into allografts. These results suggest that strategies for optimal inhibition of alloimmunity should include neutralization of infiltrating CD8 memory T cells within a very narrow window after transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18557725      PMCID: PMC2625311          DOI: 10.1111/j.1600-6143.2008.02302.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  45 in total

1.  Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.

Authors:  Yuan Zhai; Lingzhong Meng; Feng Gao; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

2.  Homeostatic proliferation is a barrier to transplantation tolerance.

Authors:  Zihao Wu; Steven J Bensinger; Jidong Zhang; Chuangqi Chen; Xueli Yuan; Xiaolun Huang; James F Markmann; Alireza Kassaee; Bruce R Rosengard; Wayne W Hancock; Mohamed H Sayegh; Laurence A Turka
Journal:  Nat Med       Date:  2003-11-30       Impact factor: 53.440

3.  CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism.

Authors:  Zhenhua Dai; Qi Li; Yinong Wang; Ge Gao; Lonnette S Diggs; George Tellides; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 4.  Infection in solid-organ transplant recipients.

Authors:  Jay A Fishman
Journal:  N Engl J Med       Date:  2007-12-20       Impact factor: 91.245

5.  Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.

Authors:  Michael A Brehm; Thomas G Markees; Keith A Daniels; Dale L Greiner; Aldo A Rossini; Raymond M Welsh
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

6.  T-cell mediated induction of allogeneic endothelial cell chemokine expression.

Authors:  Hirohito Kobayashi; Shoji Koga; Andrew C Novick; Hiroshi Toma; Robert L Fairchild
Journal:  Transplantation       Date:  2003-02-27       Impact factor: 4.939

7.  In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.

Authors:  Yifa Chen; Peter S Heeger; Anna Valujskikh
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

8.  Heterologous immunity provides a potent barrier to transplantation tolerance.

Authors:  Andrew B Adams; Matthew A Williams; Thomas R Jones; Nozomu Shirasugi; Megan M Durham; Susan M Kaech; E John Wherry; Thandi Onami; J Gibson Lanier; Kenneth E Kokko; Thomas C Pearson; Rafi Ahmed; Christian P Larsen
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 9.  Heterologous immunity: an overlooked barrier to tolerance.

Authors:  Andrew B Adams; Thomas C Pearson; Christian P Larsen
Journal:  Immunol Rev       Date:  2003-12       Impact factor: 12.988

10.  Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function.

Authors:  Marina Afanasyeva; Dimitrios Georgakopoulos; Diego F Belardi; Amrish C Ramsundar; Jobert G Barin; David A Kass; Noel R Rose
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

View more
  67 in total

1.  Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.

Authors:  Anna von Rossum; Randall Krall; Nichole K Escalante; Jonathan C Choy
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells.

Authors:  W H Kitchens; D Haridas; M E Wagener; M Song; A D Kirk; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2011-09-22       Impact factor: 8.086

3.  Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming.

Authors:  Audrea M Burns; Anita S Chong
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

Review 4.  Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.

Authors:  Alberto Sánchez-Fueyo; Terry B Strom
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

5.  Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.

Authors:  D J Lo; T A Weaver; L Stempora; A K Mehta; M L Ford; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

6.  Memory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3.

Authors:  Martin H Oberbarnscheidt; Jeffrey M Walch; Qi Li; Amanda L Williams; John T Walters; Rosemary A Hoffman; Anthony J Demetris; Craig Gerard; Geoffrey Camirand; Fadi G Lakkis
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

Review 7.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

Review 8.  Recent progress and new perspectives in studying T cell responses to allografts.

Authors:  A Valujskikh; W M Baldwin; R L Fairchild
Journal:  Am J Transplant       Date:  2010-03-26       Impact factor: 8.086

Review 9.  Memory T-cell-specific therapeutics in organ transplantation.

Authors:  Andrew J Page; Mandy L Ford; Allan D Kirk
Journal:  Curr Opin Organ Transplant       Date:  2009-12       Impact factor: 2.640

10.  Role of TNFalpha in early chemokine production and leukocyte infiltration into heart allografts.

Authors:  D Ishii; A D Schenk; S Baba; R L Fairchild
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.